Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1998;32:96-100

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Masuo, K.
Right arrow Articles by Tuck, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Masuo, K.
Right arrow Articles by Tuck, M. L.

(Hypertension. 1998;32:96-100.)
© 1998 American Heart Association, Inc.


Scientific Contributions

Familial Hypertension, Insulin, Sympathetic Activity, and Blood Pressure Elevation

Kazuko Masuo; Hiroshi Mikami; Toshio Ogihara; ; Michael L. Tuck

From the Departments of Geriatric Medicine (K.M., T.O.) and of Community Health Nursing (H.M.), Osaka University Medical School, Suita City, Osaka, Japan; and the University of California at Los Angeles School of Medicine, Veterans Administration Medical Center, Sepulveda, Calif (M.L.T.).

Correspondence to Toshio Ogihara, MD, Department of Geriatric Medicine, Osaka University Medical School, 2–2 Yamada-oka, Suita City Osaka, 565-0871, Japan.

Abstract—This study evaluated the effects of a positive family history of hypertension (FH+) on the contributions of sympathetic nervous system (SNS) activity and insulin to blood pressure elevation (BPE). The study design was longitudinal and evaluated BP, body mass index (BMI), and fasting plasma insulin and norepinephrine (NE) levels for 10 years in 557 young, nonobese Japanese men who were normotensive at entry. FH+ was defined as hypertension in first-degree relatives as verified by historical records or direct determination. BPE was defined as a >=10% rise in systolic and diastolic BP over entry levels during the 10-year period. In the total group FH+ was noted in 16%, and BPE occurred in 18% of normotensive subjects. When evaluated by FH, the prevalence of BPE was 33% in FH+ compared with 16% in FH- (P<0.05). BP levels were greater both at entry and at year 10 in the FH+ group. The absolute increment in plasma NE over 10 years was greater in the BPE group than in those without BPE (P<0.01). Of note, the rise in plasma NE levels in BPE individuals was identical in FH+ and FH- subjects. Plasma insulin increments were also greater in normotensive subjects with BPE than in normotensive subjects without BPE. However, compared with NE, development of hyperinsulinemia was more pronounced in the FH+ subjects. The results indicate that SNS hyperactivity may be a less genetically determined predictor of hypertension than is hyperinsulinemia. Because SNS changes in this initially normotensive population appeared more closely related to the development of hypertension than to hyperinsulinemia, environmental rather than genetic factors may be the main determinant of early BPE in nonobese normotensive subjects.


Key Words: family history • sympathetic nervous system • insulin • blood pressure




This article has been cited by other articles:


Home page
CirculationHome page
K. Masuo, T. Katsuya, Y. Fu, H. Rakugi, T. Ogihara, and M. L. Tuck
{beta}2- and {beta}3-Adrenergic Receptor Polymorphisms Are Related to the Onset of Weight Gain and Blood Pressure Elevation Over 5 Years
Circulation, June 28, 2005; 111(25): 3429 - 3434.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. R. Seals and F. A. Dinenno
Collateral damage: cardiovascular consequences of chronic sympathetic activation with human aging
Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H1895 - H1905.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Masuo, H. Kawaguchi, H. Mikami, T. Ogihara, and M. L. Tuck
Serum Uric Acid and Plasma Norepinephrine Concentrations Predict Subsequent Weight Gain and Blood Pressure Elevation
Hypertension, October 1, 2003; 42(4): 474 - 480.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Weyer, R. E. Pratley, S. Snitker, M. Spraul, E. Ravussin, and P. A. Tataranni
Ethnic Differences in Insulinemia and Sympathetic Tone as Links Between Obesity and Blood Pressure
Hypertension, October 1, 2000; 36(4): 531 - 537.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. F. Damiano, M. I. Roson, I. Armando, S. Nowicki, E. Dascal, L. Cuniberti, L. E. Albornoz, and Ignacio J. de la Riva ;
Potential Role of Glycerol Leading to Rat Fructose Hypertension
Hypertension, October 1, 1999; 34(4): 1007 - 1011.
[Abstract] [Full Text] [PDF]